Scilex Holding (SCLX) Shares Outstanding (Entity) (2020 - 2026)
Scilex Holding (SCLX) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 651.61 Bn | 630.85 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 470.09 Bn | 463.53 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 374.19 Bn | 367.05 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 302.72 Bn | 295.03 Bn | 11.24 Bn | 1.90 Bn |
| 5 | Astrazeneca | 257.19 Bn | 252.29 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 236.77 Bn | 222.78 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 182.67 Bn | 179.49 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 159.54 Bn | 147.84 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Gsk | 105.97 Bn | 101.81 Bn | 8.24 Bn | - |
| 10 | Scilex Holding | 38.94 Mn | -73.85 Mn | 3.97 Mn | 7.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.89 Mn |
| Dec 31, 2025 | 11,034.00 |
| Sep 30, 2025 | 11,604.00 |
| Jun 30, 2025 | 11,595.00 |
| Mar 31, 2025 | 5.07 Mn |
| Dec 31, 2024 | 3.75 Mn |
| Sep 30, 2024 | 3,627.00 |
| Jun 30, 2024 | 3.24 Mn |
| Mar 31, 2024 | 2,926.00 |
| Dec 31, 2023 | 3.72 Mn |
| Sep 30, 2023 | 4.41 Mn |
| Jun 30, 2023 | 4.07 Mn |
| Mar 31, 2023 | 4.05 Mn |
| Dec 31, 2022 | 3,835.00 |
| Sep 30, 2022 | 376,450.00 |
| Jun 30, 2022 | 491,554.00 |
| Mar 31, 2022 | 492,832.00 |
| Dec 31, 2021 | 480,951.00 |
| Sep 30, 2021 | 492,832.00 |
| Jun 30, 2021 | 394,266.00 |